Grape King Bio Statistics

Total Valuation

Grape King Bio has a market cap or net worth of TWD 21.85 billion. The enterprise value is 20.15 billion.

Market Cap	21.85B
Enterprise Value	20.15B

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	Jan 21, 2025

Share Statistics

Grape King Bio has 148.14 million shares outstanding. The number of shares has increased by 0.12% in one year.

Current Share Class	n/a
Shares Outstanding	148.14M
Shares Change (YoY)	+0.12%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	13.02%
Owned by Institutions (%)	20.44%
Float	113.90M

Valuation Ratios

The trailing PE ratio is 14.98 and the forward PE ratio is 14.06.

PE Ratio	14.98
Forward PE	14.06
PS Ratio	1.95
PB Ratio	2.18
P/TBV Ratio	2.21
P/FCF Ratio	13.54
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.60, with an EV/FCF ratio of 12.49.

EV / Earnings	13.71
EV / Sales	1.80
EV / EBITDA	6.60
EV / EBIT	7.81
EV / FCF	12.49

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.02.

Current Ratio	1.73
Quick Ratio	1.39
Debt / Equity	0.02
Debt / EBITDA	0.06
Debt / FCF	0.11
Interest Coverage	869.37

Financial Efficiency

Return on equity (ROE) is 19.56% and return on invested capital (ROIC) is 13.98%.

Return on Equity (ROE)	19.56%
Return on Assets (ROA)	11.22%
Return on Capital (ROIC)	13.98%
Revenue Per Employee	22.37M
Profits Per Employee	2.93M
Employee Count	501
Asset Turnover	0.79
Inventory Turnover	2.93

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.22% in the last 52 weeks. The beta is 0.46, so Grape King Bio's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-4.22%
50-Day Moving Average	152.47
200-Day Moving Average	151.74
Relative Strength Index (RSI)	35.82
Average Volume (20 Days)	152,329

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Grape King Bio had revenue of TWD 11.21 billion and earned 1.47 billion in profits. Earnings per share was 9.85.

Revenue	11.21B
Gross Profit	8.74B
Operating Income	2.56B
Pretax Income	2.72B
Net Income	1.47B
EBITDA	2.98B
EBIT	2.56B
Earnings Per Share (EPS)	9.85

Full Income Statement

Balance Sheet

The company has 3.38 billion in cash and 173.17 million in debt, giving a net cash position of 3.21 billion or 21.67 per share.

Cash & Cash Equivalents	3.38B
Total Debt	173.17M
Net Cash	3.21B
Net Cash Per Share	21.67
Equity (Book Value)	11.53B
Book Value Per Share	67.64
Working Capital	1.94B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.31 billion and capital expenditures -699.49 million, giving a free cash flow of 1.61 billion.

Operating Cash Flow	2.31B
Capital Expenditures	-699.49M
Free Cash Flow	1.61B
FCF Per Share	10.89

Full Cash Flow Statement

Margins

Gross margin is 78.00%, with operating and profit margins of 22.83% and 13.12%.

Gross Margin	78.00%
Operating Margin	22.83%
Pretax Margin	24.23%
Profit Margin	13.12%
EBITDA Margin	26.55%
EBIT Margin	22.83%
FCF Margin	14.40%

Dividends & Yields

This stock pays an annual dividend of 5.40, which amounts to a dividend yield of 3.66%.

Dividend Per Share	5.40
Dividend Yield	3.66%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	69.54%
Buyback Yield	-0.12%
Shareholder Yield	3.54%
Earnings Yield	6.68%
FCF Yield	7.38%

Dividend Details

Stock Splits

The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.

Last Split Date	Sep 15, 2005
Split Type	Forward
Split Ratio	1.0205

Scores

Grape King Bio has an Altman Z-Score of 6.79.

Altman Z-Score	6.79
Piotroski F-Score	n/a